SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 39 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,000 | -16.7% | 4,200 | +0.8% | 0.00% | – |
| Q2 2020 | $6,000 | 0.0% | 4,166 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 4,166 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -57.1% | 4,166 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | -6.7% | 4,166 | 0.0% | 0.00% | – |
| Q2 2019 | $15,000 | -65.1% | 4,166 | 0.0% | 0.00% | – |
| Q1 2019 | $43,000 | 0.0% | 4,166 | 0.0% | 0.00% | – |
| Q4 2018 | $43,000 | -12.2% | 4,166 | 0.0% | 0.00% | – |
| Q2 2018 | $49,000 | -10.9% | 4,166 | 0.0% | 0.00% | – |
| Q1 2018 | $55,000 | 0.0% | 4,166 | 0.0% | 0.00% | – |
| Q4 2017 | $55,000 | – | 4,166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 941,171 | $1,384,000 | 0.08% |
| EXANE DERIVATIVES | 81,600 | $119,944,000 | 0.03% |
| TIEDEMANN ADVISORS, LLC | 363,114 | $533,000 | 0.03% |
| Private Capital Advisors, Inc. | 52,335 | $77,000 | 0.02% |
| Pegasus Asset Management, Inc. | 18,750 | $28,000 | 0.02% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 59,905 | $88,000 | 0.01% |
| Lee Financial Co | 18,750 | $28,000 | 0.01% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 12,000 | $18,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $294,000 | 0.00% |
| Renaissance Technologies | 472,530 | $695,000 | 0.00% |